Literature DB >> 33867735

Disease Knowledge and General Self-Efficacy Among Adolescents with Thalassemia Major and Their Parents' Perspective.

Rekha Kharyal1, Vanita Kumari1, V T Mrunalini2, Monika Naik1, Poonam Joshi1, Tulika Seth1.   

Abstract

Thalassemia major can affect physical, psycho-social and economic life of patients and their parents. The aim of the study was to assess the disease knowledge and general self-efficacy among adolescents with Thalassemia major and their parents' perspective with a view to develop an informational booklet on thalassemia. In a cross-sectional study 50 adolescents along with 48 parents were recruited from the hematology day care centre of a tertiary care facility. Ethical clearance from institute ethics committee, written informed consent from parent and assent from the adolescent were taken. Consecutive participants those who consented were enrolled in the study. Adolescents between the age group of 10-18 years, and their parents completed the self-developed subject data sheet, knowledge questionnaire and standardized general self-efficacy tools. The mean knowledge scores of the adolescent and their parents related to thalassemia were 13.9 ± 2.9 and 13.7 ± 3.6 respectively, while the perceived GSE scores of the adolescent along with the parents' perspective were 30.1 ± 6.1 and 29.3 ± 6.5. Positive correlation between the adolescents' knowledge with GSE (r = 0.464, p = 0.007) was observed. The knowledge of the adolescents and their parents showed significant association with the education (p = 0.001, p = 0.002) residence (p = 0.04 and p = 0.01) and parents' employment (p = 0.04). The knowledge of adolescents with thalassemia and their parents is limited. There is need to counsel the adolescents and their parents about the disease and its management in order to improve the GSE of these adolescents. © Indian Society of Hematology and Blood Transfusion 2020.

Entities:  

Keywords:  Adolescent with thalassemia major; General self efficacy; Knowledge; Parents of adolescent with thalassemia major

Year:  2020        PMID: 33867735      PMCID: PMC8012458          DOI: 10.1007/s12288-020-01335-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

Review 1.  Pulmonary hypertension in beta-thalassemia.

Authors:  Athanasios Aessopos; Dimitrios Farmakis
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

2.  Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.

Authors:  M D Cappellini; L Robbiolo; B M Bottasso; R Coppola; G Fiorelli; A P Mannucci
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

3.  A natural history study of adolescents and young adults with sickle cell disease as they transfer to adult care: a need for case management services.

Authors:  Elizabeth A Wojciechowski; Anita Hurtig; Louise Dorn
Journal:  J Pediatr Nurs       Date:  2002-02       Impact factor: 2.145

4.  Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India.

Authors:  Nishi Madan; Satendra Sharma; S K Sood; Roshan Colah; Late H M Bhatia
Journal:  Indian J Hum Genet       Date:  2010-01

5.  Patterns of physical growth and dental development in Jordanian children and adolescents with thalassemia major.

Authors:  Faiez N Hattab
Journal:  J Oral Sci       Date:  2013-03       Impact factor: 1.556

6.  Effect of booklet and combined method on parents' awareness of children with beta-thalassemia major disorder.

Authors:  Ali Hassanpour Dehkordi; M Saeed Heydarnejad
Journal:  J Pak Med Assoc       Date:  2008-09       Impact factor: 0.781

7.  Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy.

Authors:  Odysseas Platis; Georgios Anagnostopoulos; Kallisteni Farmaki; Markos Posantzis; Efstathios Gotsis; Georgios Tolis
Journal:  Pediatr Endocrinol Rev       Date:  2004-12

8.  Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study.

Authors:  Ali Taher; Amal El-Beshlawy; Mohsen S Elalfy; Kusai Al Zir; Shahina Daar; Dany Habr; Ulrike Kriemler-Krahn; Abdel Hmissi; Abdullah Al Jefri
Journal:  Eur J Haematol       Date:  2009-01-28       Impact factor: 2.997

Review 9.  The α-thalassemias.

Authors:  Frédéric B Piel; David J Weatherall
Journal:  N Engl J Med       Date:  2014-11-13       Impact factor: 91.245

10.  Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Nicos Skordis; Christos Kattamis; Michael Angastiniotis; Mehran Karimi; Mohd Abdel Daem Mohd Yassin; Ahmed El Awwa; Iva Stoeva; Giuseppe Raiola; Maria Concetta Galati; Elsaid M Bedair; Bernadette Fiscina; Mohamed El Kholy
Journal:  Indian J Endocrinol Metab       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.